Immunohistochemical markers for arthritis in psoriasis

Area of Science:

• Dermatology
• Immunology
• Rheumatology

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Psoriatic arthritis (PA) affects a subset of psoriasis patients, presenting unique challenges in diagnosis.
• Identifying specific markers for PA is crucial for early intervention.

Purpose of the Study:

• To investigate immunohistological differences in skin from patients with psoriatic arthritis (PA), psoriasis without arthritis, and healthy controls.
• To identify potential skin-based biomarkers for distinguishing PA from psoriasis alone.

Main Methods:

• Skin biopsies were collected from patients with PA (n=15), psoriasis (n=5), and normal controls (n=4).
• Samples were stained using monoclonal antibodies for T cells (CD3, CD8, CD4, CD45Ro), B cells (CD20), macrophages, vascular endothelium, and Langerhans cells.
• Immunohistochemical analysis quantified cell populations and assessed DR+ keratinocytes.

Main Results:

• Patients with PA exhibited significantly higher numbers of CD45Ro T-cells and increased vascularity compared to both psoriasis and normal skin (p < 0.02).
• B-cells were present in PA skin but absent in psoriasis without arthritis and normal skin (p < 0.02).
• The epidermis of PA patients showed significantly more DR+ keratinocytes than those with psoriasis alone (p < 0.02).

Conclusions:

• Increased CD45Ro T-cells, enhanced vascularity, presence of B-cells, and elevated DR+ epidermal cells are significant indicators of arthritis in psoriasis patients.
• These immunohistological findings may serve as valuable markers for diagnosing psoriatic arthritis.
• The study highlights distinct skin immune profiles differentiating PA from cutaneous psoriasis.